Title:
腫瘍抗原
Document Type and Number:
Japanese Patent JP4900884
Kind Code:
B2
Abstract:
Tumor antigen inducing and/or activating HLA-A2-restricted tumor-specific cytotoxic T lymphocytes that is activated by recognizing HLA-A2 and a tumor antigen peptide, and a peptide or polypeptide derived from the tumor antigen, a polynucleotide encoding the peptide or a complementary strand polynucleotide thereof, a transformant comprising a recombinant vector which comprises the polynucleotide are provided.
More Like This:
Inventors:
Kyogo Ito
Application Number:
JP2002516288A
Publication Date:
March 21, 2012
Filing Date:
July 30, 2001
Export Citation:
Assignee:
Green Peptide Co., Ltd.
International Classes:
C12N15/09; A61K31/7088; A61K35/12; A61K35/56; A61K35/66; A61K35/76; A61K38/00; A61K39/00; A61K39/395; A61K45/00; A61K48/00; A61P1/00; A61P1/18; A61P35/00; A61P37/04; A61P43/00; C07K14/47; C07K14/82; C07K16/32; C12N1/15; C12N1/19; C12N1/21; C12N5/0783; C12N5/10; C12P21/02; C12P21/08; G01N33/15; G01N33/50; G01N33/53; G01N33/566; G01N33/574
Domestic Patent References:
| JP2000189168A | 2000-07-11 |
Foreign References:
| WO1997021807A1 | 1997-06-19 | |||
| US5874231A | 1999-02-23 |
Attorney, Agent or Firm:
Takashi Shoji